• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Practical Benefit-Risk Assessment in Pharmacovigilance From Safety Signals to Regulatory Decisions

Practical Benefit-Risk Assessment in Pharmacovigilance From Safety Signals to Regulatory Decisions

Paperback

Medical Reference

ISBN13: 9798237377460
Publisher: Dr. Hafez Selim MD, PhD
Published: Sep 24 2026
Pages: 658
Weight: 3.31
Height: 1.32 Width: 8.50 Depth: 11.00
Language: English

Every periodic safety report ends with the same sentence: the benefit-risk balance remains favourable. Regulatory guidance is excellent at describing what that conclusion must look like on the page. ICH E2C(R2) tells you where the integrated analysis goes. ICH M4E(R2) sets out the subsection structure. GVP Module V defines which risks belong in the safety specification. The FDA framework gives you a grid and explains what belongs in each cell.

Also in

Medical Reference